Idexx Laboratories, Inc.

Idexx Corporation

Philip R Andersen

Quentin J Tonelli

Thomas P O'Connor

Melissa Jane Beall

Stacey Pazar Huth

Marilyn Strong-Townsend

Ku-chuan Hsiao

Jesse Buch

Barbara O'Brien

Thomas Patrick O'Connor, Jr

Eugene Regis Krah, Iii

Randall G Groat

Jill Saucier

Eugene Regis

Eugene Regis Krah

Marilyn I Strong-Townsend

Ku-Chuan Hsiao

Melissa Jane Beal

Barbara O'Brien Graff

Marylin I Strong-Townsend

Thomas Patrick O'CONNER

Barbara O'brien-Graff

Method, device and kit for the detection of antibodies directed to Feline Immunodeficiency Virus (FIV). The method includes contacting the felid biological sample with FIV env polypeptide and detecting whether the polypeptide substantially binds to the antibody in the biological sample. The method will detect FIV antibodies in a sample from animals that have been naturally infected but the method will not detect antibodies in a sample from animals that have not been infected and that have not been vaccinated with an FIV vaccine after within about the previous five to eight weeks.

Detection of feline immunodeficiency virus

Isolated nucleic acid molecules having a nucleotide sequence encoding feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Isolated feline pancreatic lipase polypeptides, splice variants, allelic variants, and fragments thereof. Host cells comprising a vector containing the polynucleotide sequences and methods for expressing the polypeptides. The generation of monoclonal antibodies that specifically binds to the feline pancreatic lipase polypeptides, and cell lines secreting the monoclonal antibodies. Methods for determining the presence or amount of feline pancreatic lipase in a biological sample. The methods include using standards or calibrators of recombinant feline pancreatic lipase to quantify the lipase in a sample. Devices and kits for performing methods for detecting feline pancreatic lipase in biological samples.

Feline pancreatic lipase

An isolated envelope polypeptide of Feline Immunodeficiency Virus (FIV) that reacts specifically with a gp-130 envelope specific monoclonal antibody. Immunoassays using such isolated polypeptides are also disclosed.

Polypeptides of feline T-cell lymphotropic lentivirus

Purified polypeptides of Feline Immunodeficiency Virus (FIV) are disclosed. The polypeptides of the invention include p10, p15, p26, gp40, gp100 and gp130.

Polypeptides of feline T-cell lymphotrophic lentivirus

Monoclonal antibodies specific for an epitope of an FIV-encoded antigen.

Monoclonal antibodies to feline-T-lymphotropic lentivirus

Growing community of inventors

Portland, ME, United States of America

Philip R Andersen